C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
01/2000
01/26/2000	CN1242367A Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
01/26/2000	CN1048722C (S) (+)-2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbonylmethyl]-benzoic acid pharmaceutical compositions contg. same, and process for prepn.
01/25/2000	US6017928 Retroviral protease inhibiting compounds
01/19/2000	EP0971915A1 Method for preparing 2-thienylethylamine derivatives
01/19/2000	EP0971898A1 Substituted isoquinolines as ultra short acting neuromuscular blockers
01/19/2000	EP0672038B1 Herbicides
01/19/2000	CN1048492C Quinuclidine derivatives and its preparation
01/18/2000	US6015910 Intermediates to pesticidal 5-amino-4-ethylsulfinyl-1-arylpryazoles
01/18/2000	US6015824 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders
01/18/2000	CA2035314C Triazole antifungal agents
01/12/2000	EP0970073A1 Process for preparing eprosartan
01/12/2000	EP0970063A1 Process for the preparation of substituted thiazolidinedione
01/12/2000	EP0969819A2 New crystalline form of omeprazole
01/12/2000	CN1241181A Pharmaceutical compounds
01/12/2000	CN1241175A Production of pyridazine herbicides
01/11/2000	US6013796 Simplification, efficiency, nontoxic
01/06/2000	WO2000000197A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists
01/06/2000	CA2327888A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists
01/05/2000	EP0968158A1 Preparation of preparing substituted indanones
01/04/2000	US6011048 Thiazole benzenesulfonamides as β3 agonists for treatment of diabetes and obesity
01/04/2000	US6011029 Benzodiazepine compounds
12/1999
12/29/1999	WO1999067226A1 Non-yellowing para-tertiary-alkyl phenyl substituted triazine and pyrimidine ultraviolet light absorbers
12/29/1999	WO1999057125A3 Hygromycin a derivatives
12/29/1999	EP0966453A1 Saccharine-5-carbonyl-cyclohexane-1,3,5-trione derivatives, their preparation and their use as herbicides
12/29/1999	EP0966448A1 Pyrazine compounds
12/29/1999	EP0654031B1 Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
12/29/1999	CA2335580A1 Non-yellowing triazine and pyrimidine ultraviolet light absorbers
12/28/1999	US6008365 Adrenoreceptor agonists and dopamine da2-receptor agonists, useful in the treatment of obstructive airway diseases
12/28/1999	US6008355 Oxidizing codeine to form codeinone, converting codeinone to oxycodone in a two step one pot reaction: reacting codeinone with hydrogen peroxide in water in presence of an acid to form 14-hydroxycodeinone then hydrogenating the intermediate
12/28/1999	US6008354 Protecting hydroxy group of morphine in 3 and 6 position, demethylating n-methyl on 17 position and hydrolizing the acyl group, forming 17-benzyl-3(o)protected group, oxidizing to form intermediate, hydrogenation of intermediate
12/28/1999	CA2037150C Retinoids
12/23/1999	WO1999065915A1 Polymorphic clopidogrel hydrogenesulphate form
12/23/1999	WO1999065488A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
12/23/1999	WO1999065482A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
12/23/1999	WO1999065311A1 Composition for keeping away vermin
12/23/1999	WO1998054171A8 Novel form of s-omeprazole
12/23/1999	CA2335112A1 Therapeutic combinations for musculoskeletal frailty
12/23/1999	CA2335078A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
12/23/1999	CA2329932A1 Composition for keeping away vermin
12/22/1999	CN1239476A Process for selective derivatization of taxanes
12/22/1999	CN1047595C Prepn. method of aminocoumaran derivatives
12/21/1999	US6005084 Asymmetric triphenylenedioxazine compounds
12/21/1999	US6004974 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines
12/21/1999	US6004973 Pharmaceutical compositions comprising rafamycin coprecipitates
12/16/1999	WO1999064417A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
12/16/1999	WO1999064411A1 Tetrahydroquinoline derivatives as glycine antagonists
12/16/1999	CA2333332A1 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
12/15/1999	EP0963987A2 Spiro(piperidine-4,1'-pyrrolo(3,4-c)pyrrole)
12/15/1999	EP0963985A2 Di-or triaza-spiro(4,5)decane derivatives
12/15/1999	EP0963984A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
12/15/1999	CN1047386C Novel spiro [indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as drug
12/14/1999	US6001998 Macrocyclic lactone compounds and their production process
12/09/1999	WO1999062883A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
12/09/1999	WO1999043285A3 Sulphonamide derivatives
12/08/1999	EP0784620B1 N-substituted piperidinyl bicyclic benzoate derivatives
12/08/1999	CN1237967A Processes and intermediates for preparation of oxazoline derivatives
12/08/1999	CN1237961A Aminoguanidines and alkoxyguanidines as protease inhibitors
12/08/1999	CN1237580A Phosphononooxymethyl ethers of taxame derivatives
12/08/1999	CN1047168C (S)-a-phenyl-2-pyridineethanamine(s)-malate, and its preparing method and use
12/07/1999	US5998429 Azabicyclic esters of carbamic acids useful in therapy
12/07/1999	US5998412 Sulfamide-metalloprotease inhibitors
12/02/1999	WO1999061444A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/02/1999	WO1999061421A1 A NOVEL VLA-4 INHIBITOR: oMePUPA-V
12/01/1999	EP0960100A1 Substituted 4-benzoyl-pyrazoles
11/1999
11/30/1999	US5994344 Bronchitis therapy
11/25/1999	WO1999059972A1 Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists
11/24/1999	EP0959076A1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics
11/24/1999	EP0959075A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
11/24/1999	EP0958289A1 Amino acid ester containing azole antifungals
11/24/1999	EP0957913A1 N-linked sulfonamides of heterocyclic thioesters
11/24/1999	CN1236366A Amino acid ester containing azole antifungals
11/24/1999	CN1235973A Sidechain-bearing taxanes
11/24/1999	CN1046720C Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
11/24/1999	CN1046711C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
11/18/1999	WO1999058509A1 Method for producing isoxazoline-3-yl-acyl benzene
11/18/1999	WO1999058502A1 Heterocyclic inhibitors of p38
11/18/1999	CA2727762A1 Process for synthesizing thioether precursors of herbicides by reaction of anilines with dialkyl disulfides in the presence of an alkyl nitrite
11/17/1999	EP0957102A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
11/17/1999	EP0956284A1 Process for selective derivatization of taxanes
11/17/1999	CN1046525C Compounds containing fused bicyclic ring and preparation thereof
11/17/1999	CN1046503C Preparation of aromatic pyrrole compounds
11/16/1999	CA2137811C Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/16/1999	CA2064815C Therapeutic heterocyclic compounds
11/16/1999	CA2036426C Sulphur-based stabilizers for 3-isothiazolones
11/11/1999	WO1999057127A1 2'-deoxy hygromycin derivatives
11/11/1999	WO1999057125A2 Hygromycin a derivatives
11/11/1999	WO1999057113A1 Heterocyclic derivatives which inhibit factor xa
11/11/1999	WO1999046240A3 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
11/11/1999	CA2331042A1 Heterocyclic derivatives which inhibit factor xa
11/10/1999	EP0547165B1 Process for the Preparation of Water-Soluble Camptothecin Analogues, as well as the compounds 10-Hydroxy-11-C(1-6)-alkoxycamptothecin
11/10/1999	CN1234803A N heterocyclic substituted adenosine derivatives
11/10/1999	CN1234400A Oxodiethylenediamine derivative and light stabilized composition
11/10/1999	CN1046283C Process for preparation of 9-amino camptothecin
11/04/1999	WO1999055676A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases
11/04/1999	DE19820722C1 Preparation of benzoyl pyrazole derivative herbicides, in single stage from hydroxypyrazole, bromobenzene and carbon monoxide
11/04/1999	CA2330304A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases
11/02/1999	US5977384 Benzothiazolone derivatives
11/02/1999	US5977136 Tetrahydroquinolines as NMDA antagonists
11/02/1999	US5977124 β-adrenergic agonists
11/02/1999	US5977105 Compounds

1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 105